We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

FDA Approves ACTEMRA® for the Treatment of Moderately to Severely Active Rheumatoid Arthritis

News   Jan 11, 2010

 
FDA Approves ACTEMRA® for the Treatment of Moderately to Severely Active Rheumatoid Arthritis
 
 
 

RELATED ARTICLES

Novel Way to Generate Molecules for Drug Development

News

Chemists at The Ohio State University have developed a new and improved way to generate molecules that can enable the design of new types of synthetic drugs.

READ MORE

Having a Heavier First-Born or Shorter Pregnancy May Increase Mother’s Breast Cancer Risk

News

Short first pregnancies and having a heavier first-born child may slightly increase a mother’s risk of breast cancer, a new study has found.

READ MORE

How to Define Spectrums of Biomarker Outcomes

News

Defining the full spectrum of human disease associated with a biomarker is necessary to advance the biomarker into clinical practice.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE